The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Raise and decline of KRAS mutant clones in colorectal cancers (CRCs) treated with multiple rounds of anti-EGFR antibodies.
 
Giulia Siravegna
No Relationships to Disclose
 
Benedetta Mussolin
No Relationships to Disclose
 
Michela Buscarino
No Relationships to Disclose
 
Giorgio Corti
No Relationships to Disclose
 
Giovanni Crisafulli
No Relationships to Disclose
 
Agostino Ponzetti
No Relationships to Disclose
 
Chiara Cremolini
No Relationships to Disclose
 
Simona Lamba
No Relationships to Disclose
 
Antonio Avallone
No Relationships to Disclose
 
Giuseppe Rospo
No Relationships to Disclose
 
Silvio Veronese
No Relationships to Disclose
 
Alfredo Budillon
No Relationships to Disclose
 
Clara Montagut
No Relationships to Disclose
 
Patrizia Racca
No Relationships to Disclose
 
Ryan Bruce Corcoran
Honoraria - GlaxoSmithKline
Consulting or Advisory Role - Avidity Nanomedicines; Merrimack; Taiho Pharmaceutical
 
Federica Di Nicolantonio
No Relationships to Disclose
 
Fotios Loupakis
Consulting or Advisory Role - Amgen; Sanofi
Speakers' Bureau - Amgen; Bayer; Roche; Sanofi
Research Funding - Merck Serono; Roche
 
Salvatore Siena
Stock and Other Ownership Interests - Ignyta
Honoraria - Amgen; Bayer
Consulting or Advisory Role - Amgen; Bayer; Ignyta; Roche/Genentech; Sanofi
Speakers' Bureau - Amgen; Bayer
Research Funding - Bayer (Inst)
Patents, Royalties, Other Intellectual Property - Amgen
Travel, Accommodations, Expenses - Amgen; Bayer; Roche
 
Andrea Sartore-Bianchi
No Relationships to Disclose
 
Alberto Bardelli
Stock and Other Ownership Interests - Horizon Discovery
Consulting or Advisory Role - Biocartis; Horizon Discovery; Trovagene